• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2014 Fiscal Year Final Research Report

Examination of a different membranes on cytokine adsorption on circulating cytokine and search of a biomarker as a prognosticator in a sepsis rat continuous heamodiafiltration model

Research Project

  • PDF
Project/Area Number 24592732
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Emergency medicine
Research InstitutionUniversity of Yamanashi

Principal Investigator

HARII Norikazu  山梨大学, 総合研究部, 准教授 (80377522)

Co-Investigator(Kenkyū-buntansha) MATSUDA Kenichi  山梨大学, 総合研究部, 教授 (60282480)
GOTO Junko  山梨大学, 総合研究部, 助教 (60530102)
YANAGISAWA Masahiko  山梨大学, 総合研究部, 助教 (90597022)
Project Period (FY) 2012-04-01 – 2015-03-31
Keywords血液浄化療法 / 敗血症性多臓器不全 / ラットエンドトキシンショックモデル
Outline of Final Research Achievements

Sepsis is a systemic inflammatory response syndrome caused by several infections. Excessive production of inflammatory mediators like cytokines and chemokines may develop multiple organ failure leading to death. Although hemodiafiltration is used as a renal replacement therapy, it is often considered for the treatment of septic renal failure with the concept of modulating immune response and ameliorating failure of other organs. Various membranes for hemodiafiltraion are commercialized and in each having their peculiar removal characteristics of the substance in blood. It is still unclear which membrane is suitable for the treatment of severe sepsis. We have been established hemodiafiltraion system for entdotoxin shock rat. We have studied the adsorption of influencing circulating levels of inflammatory mediators like cytokines for comparing several membranes and identified the polyarylate/polyethylsulfon(PEPA) membrane efficiently adsorbed the serum interleukin-6.

Free Research Field

集中治療医学

URL: 

Published: 2016-06-03  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi